L'Oréal's Episkin buys out SkinEthic - tissue making firm
06 Mar '06
2 min read
“The acquisition provides SkinEthic with a new approach to the market and brings with it the research capability that will benefit all present and future customers”, added Doctor Martin Rosdy, founder of SkinEthic.
L'Oréal supports the objective of the elimination of laboratory animal testing and is working on various alternative methods that must be validated by competent scientific authorities.
L'Oréal : Worldwide Reach with 17 brands Well-being is a universal aspiration, but means many things to many people. Because there is no single model of beauty, the group has 17 distinct and complementary brands recognized worldwide. Each brand has distinct roots and offers a variety of products to suit the diverse needs of different individuals, tastes and lifestyles.
France based Tissue production company SkinEthic Laboratories is using it's proprietary technology based on chemically defined tissue culture procedures, large quantities of different human tissues including epidermis (with or without melanocytes), corneal, oral, gingival, oesophageal epithelium, alveolar and vaginal mucosa, featuring normal functionality and ultra-structure, equivalent to those of humans in vivo, are produced weekly in tissue culture inserts of different sizes.